Big Molecule Watch

ID: 1b83e026-2619-30fb-68c4

/

Claimed Record

/

Organization: Goodwin Procter

Year in Review: Top Five Legal Developments of 2020 Impacting Biosimilars

Big Molecule Watch · December 31, 2020

Year in Review: Top U.S. Biosimilars-Related Regulatory Developments of 2020

Big Molecule Watch · December 29, 2020

President Signs Consolidated Appropriations Act Including Biosimilars Related Provisions

Big Molecule Watch · December 29, 2020

Federal Circuit Affirms PTAB Finding that Rituxan® Biogen Patent is Invalid

Big Molecule Watch · December 21, 2020

Boehringer Ingelheim Files Citizen Petition Urging FDA to Address “Strength” Definition for Biosimilars, Citing Concerns Over Evergreening

Big Molecule Watch · December 17, 2020

Practice Areas

Intellectual Property

Jurisdictions